SOURCE: Phenomenex, Inc.

Phenomenex logo

July 20, 2016 14:45 ET

Introducing the New Lux AMP Chiral Column

TORRANCE, CA--(Marketwired - July 20, 2016) - Over 30 years of strong separation science focus at Phenomenex -- combined with innovative manufacturing, packing and sorbent technologies -- has now led to the development of a novel LC media specifically designed for the separation of amphetamine and substituted amphetamine enantiomers, like methamphetamine.

While other chiral columns are limited to use in only acidic/neutral mobile phases, the Lux AMP chiral stationary phase was designed to withstand the rigors of chiral reversed phase methods from pH 1-11.5. This lets chemists take advantage of highly basic conditions that allow de-ionized forms of basic analytes to fully interact with the multiple retention mechanisms (such as hydrogen bonding) found within the Lux AMP column. Additionally, the 3 micron particle size provides excellent column efficiency, improved resolving power and increased sensitivity for use with rapid methods on both HPLC and UHPLC instrumentation.

Another excellent benefit of Lux 3 micron AMP is that each batch is LC/MS tested for the chiral separation of amphetamine and methamphetamine enantiomers. Each column is also individually performance-tested to confirm dependability and reproducibility.

Learn more about Lux AMP chiral columns here.

Image Available: http://www.marketwire.com/library/MwGo/2016/7/20/11G107376/Images/Lux_AMP_Pic-c877963b6d10b09f9363a495702ea723.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/7/20/11G107376/Images/AMP-MDMA-EPHED-3568fc56aac2be85ba65d4860544e249.JPG

Contact Information